Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Opexa Therapeutics, Inc. (OPXA) Starts Presentation at the Aegis Healthcare Conference

Opexa Therapeutics, Inc. is a biopharmaceutical company that develops personalized cellular therapies to treat multiple sclerosis (MS) using its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. For more information, visit the company’s website at

This entry was posted in Aegis Conference. Bookmark the permalink.

Comments are closed.